This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beamer, G. L.
Right arrow Articles by Turner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beamer, G. L.
Right arrow Articles by Turner, J.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, March 2008, p. 474-483, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00408-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Peripheral Blood Gamma Interferon Release Assays Predict Lung Responses and Mycobacterium tuberculosis Disease Outcome in Mice{triangledown}

Gillian L. Beamer,1,2 David K. Flaherty,3 Bridget Vesosky,1 and Joanne Turner1,2*

Center for Microbial Interface Biology, The Ohio State University, Columbus, Ohio 43210,1 Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio 43210,2 Vanderbilt Medical Center, Vanderbilt University, Nashville, Tennessee 372323

Received 28 September 2007/ Returned for modification 29 October 2007/ Accepted 19 December 2007

Current diagnostic tests for tuberculosis (TB) are not able to distinguish active disease from latent Mycobacterium tuberculosis infection, nor are they able to quantify the risk of a latently infected person progressing to active TB. There is interest, however, in adapting antigen-specific gamma interferon (IFN-{gamma}) release assays (IGRAs) to predict disease outcome. In this study, we used the differential susceptibilities of inbred mouse strains to M. tuberculosis infection to evaluate the prognostic capabilities of IGRAs. Using lung and blood cultures, we determined that CBA/J, DBA/2, and C3H/HeJ mice (models of heightened risk of progression to active TB) produced less antigen-specific IFN-{gamma} in response to M. tuberculosis culture filtrate proteins and early secreted antigenic target-6 than the relatively resistant C57BL/6 mouse strain. Additionally, reduced IFN-{gamma} secretion in supernatants reflected a reduced frequency of IFN-{gamma}-responding cells in the lung and blood and not a specific defect in IFN-{gamma} secretion at the single-cell level. Importantly, detection of antigen-specific IFN-{gamma} from blood cultures accurately reflected lung responses, indicating that blood can be an appropriate test tissue in humans. Furthermore, reduced antigen-specific IFN-{gamma} production and low frequencies of IFN-{gamma}-responding cells from peripheral blood predicted increased risk of TB disease progression across genetically diverse TB disease-susceptible mouse strains, suggesting that similar results may occur in humans. The development of efficacious predictive diagnostic tests for humans would lead to targeted therapy prior to progression to active TB, reducing transmission, incidence, and prevalence rates while maximizing the use of public health resources.

* Corresponding author. Mailing address: 1010 Biomedical Research Tower, The Ohio State University, 460 West 12th Avenue, Columbus, OH 43210. Phone: (614) 292-6724. Fax: (614) 292-9616. E-mail: joanne.turner{at}osumc.edu

{triangledown} Published ahead of print on 9 January 2008.

Clinical and Vaccine Immunology, March 2008, p. 474-483, Vol. 15, No. 3
1071-412X/08/$08.00+0     doi:10.1128/CVI.00408-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Beamer, G. L., Flaherty, D. K., Assogba, B. D., Stromberg, P., Gonzalez-Juarrero, M., de Waal Malefyt, R., Vesosky, B., Turner, J. (2008). Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice. J. Immunol. 181: 5545-5550 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»